Differential regulation of estrogen receptor alpha, glucocorticoid receptor and retinoic acid receptor alpha transcriptional activity by melatonin is mediated via different G proteins

Journal of Pineal Research

Volumn 38, Issue 4, 2005, Pages 231-239

  Kiefer, Todd L ^a   Lai, Ling ^a   Yuan, Lin ^a   Dong, Chunmin ^a   Burow, Matthew E ^a   Hill, Steven M ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Estrogen receptor; G i protein; Glucocorticoid receptor; Melatonin; MT1 receptor; Retinoic acid receptor

Indexed keywords

DEXAMETHASONE; ESTROGEN RECEPTOR ALPHA; G PROTEIN COUPLED RECEPTOR; GLUCOCORTICOID RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT 2; MELATONIN; MELATONIN 1 RECEPTOR; PERTUSSIS TOXIN; PROTEIN SUBUNIT; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; UNCLASSIFIED DRUG; PRIMER DNA; RETINOIC ACID RECEPTOR;

ARTICLE; BREAST CANCER; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA BINDING; ESTROGEN RESPONSE; HORMONAL REGULATION; HORMONE RECEPTOR INTERACTION; HORMONE RESPONSE; HUMAN; HUMAN CELL; LIGAND BINDING; MODULATION; PROTEIN EXPRESSION; RECEPTOR BINDING; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; CELL LINE; DRUG EFFECT; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSCRIPTION; NUCLEOTIDE SEQUENCE; PHYSIOLOGY;

BASE SEQUENCE; CELL LINE; DNA PRIMERS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ESTROGEN RECEPTOR ALPHA; GTP-BINDING PROTEINS; HUMANS; MELATONIN; RECEPTORS, GLUCOCORTICOID; RECEPTORS, RETINOIC ACID; TRANSCRIPTION, GENETIC;

EID: 22844437748     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2004.00198.x     Document Type: Article

References (42)

1. BRZEZINSKIB A. Melatonin in humans. N Engl J Med 1997; 336:186-195.
2. EBISAWAT T, KRANE S, LERNER MR, REPPERT SM. Expression cloning of a high-affinity melatonin receptor from Xenopus dermal melanophores. Proc Natl Acad Sci USA 1994; 91:6133-6137.
3. REPPERT SM, GODSON C, MAHLE CD, WEAVER D, SLAUGENHAUPT SA, GUSELLA GF. Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proc Natl Acad Sci USA 1995; 92:8734-8738.
4. ROCA, AL, GODSON C, WEAVER DR, REPPERT SM. Structure, characterization, and expression of the gene encoding the mouse Mel1a melatonin receptor. Endocrinology 1996; 137:3469-3477.
5. WEAVER DR, REPPERT SM. The Mel1a melatonin receptor gene is expressed in human suprachiasmatic nuclei. Neuroreport 1996; 8:109-112.
6. AL-GHOUL WM, HERMAN MD, DUBOCOVICH ML. Melatonin receptor subtype expression in human cerebellum. Neuroreport 1998; 9:4063-4068.
7. POZO D, DELGADO M, FERNANDEZ-SANTOS JM et al. Expression of the Mel1a-melatonin receptor mRNA in T and B subsets of lymphocytes from rat thymus and spleen. FASEB J 1997; 11:466-473.
8. TING KN, BLAYLOCK NA, SUGDEN D, DELAGRANGE P, SCALBERT E, WILSON VG. Molecular and pharmacological evidence for mt1 melatonin receptor subtype in the tail artery of juvenile Wistar rats. Br J Pharmacol 1999; 127:987-995.
9. RAM PT, KIEFER T, SILVERMAN M, SONG Y, BROWN GM, HILL SM. Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors. Mol Cell Endocrinol 1998; 141:53-64.
10. NILES LP, WANG J, SHEN L, LOBB DK, YOUNGLAI EV. Melatonin receptor mRNA expression in human granulosa cells. Mol Cell Endocrinol 1999; 156:107-110.
11. DUBOCOVICH ML, YUN K, AL-GHOUL WM et al. Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms. FASEB J 1998; 12:1211-1220.
12. ROKA F, BRYDON L, WALDHOER M et al. Tight association of the human Mel(1a)-melatonin receptor and G(i): precoupling and constitutive activity. Mol Pharmacol 1999; 56:1014-1024.
13. q/11 proteins. Mol Endocrinol 1999; 13:2025-2038.
14. COS S, BLASK DE. Effects of the pineal hormone melatonin on the anchorage-independent growth of human breast cancer cells (MCF-7) in a clonogenic culture system. Cancer Lett 1990; 50:115-119.
15. COS S, BLASK DE, LEMUS-WILSON A, HILL AB. Effects of melatonin on the cell cycle kinetics and "estrogen-rescue" of MCF-7 human breast cancer cells in culture. J Pineal Res 1991; 10:36-42.
16. GILAD E, LAUFER M, MATZKIN H, ZISAPEL N. Melatonin receptors in PC3 human prostate tumor cells. J Pineal Res 1999; 26:211-220.
17. MORETTI RM, MARELLI MM, MAGGI R, DONDI D, MOTTA M, LIMONTA P. Antiproliferative action of melatonin on human prostate cancer LNCaP cells. Oncol Rep 2000; 7:347-351.
18. HILL SM, BLASK DE. Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res 1989; 48:6121-6126.
19. BALDWIN WS, TRAVLOS GS, RISINGER JI, BARRETT JC. Melatonin does not inhibit estradiol-stimulated proliferation in MCF-7 and BG-1 cells. Carcinogenesis 1998; 19:1895-1900.
20. PETRANKA J, BALDWIN W, BIERMANN J et al. The oncostatic action of melatonin in an ovarian carcinoma cell line. J Pineal Res 1999; 26:129-136.
21. KANISHI Y, KOBAYASHI Y, NODA S, ISHIZUKA B, SAITO K. Differential growth inhibitory effect of melatonin on two endometrial cancer cell lines. J Pineal Res 2000; 28:227-233.
22. DAS GUPTA TK, TERZ J. Influence of pineal gland on the growth and spread of melanoma in the hamster. Cancer Res 1967; 27:1306-1311.
23. BUZZELL GR. Studies on the effects of the pineal hormone melatonin on an androgen-insensitive rat prostatic adenocarcinoma: the Dunning R 3327 HIF tumor. J Neural Transm 1988; 72:131-140.
24. ANISIMOV VN, POPOVICH IG, ZABEZHINSKI MA. Melatonin and colon carcinogenesis: I. Inhibitory effect of melatonin on development of intestinal tumors induced by 1,2-dimethylhydrazine in rats. Carcinogenesis 1997; 18:1549-1553.
25. BLASK DE, HILL SM, ORSTEAD KM, MASSA JS. Inhibitory effects of the pineal hormone melatonin and underfeeding during the promotional phase of 7,12-dimethylbenzanthracene-(DMBA)-induced mammary tumorigenesis. J Neural Transm 1986; 67:125-138.
26. BLASK DE, HILL SM. Effects of melatonin on cancer: studies on MCF-7 human breast cancer cells in culture. J Neural Transm Suppl 1986; 21:433-449.
27. YUAN L, COLLINS AR, DAI J, DUBOCOVICH ML, HILL SM. MT1 melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells. Mol and Cell Endocrinol 2002; 192:147-156.
28. KIEFER TL, YUAN L, RAM PT, HILL SM. Melatonin inhibits estrogen receptor transactivation and cAMP levels in MCF-7 human breast cancer cells. Breast Cancer Res Treat 2002; 71:37-45.
29. ECK KM, YUAN L, DUFFY L et al. A sequential treatment regimen with melatonin and all-trans retinoic acid induces apoptosis in MCF-7 tumour cells. Br J Cancer 1998; 7:2129-2137.
30. TEPLITZKY SR, KIEFER TL, CHENG Q et al. Chemoprevention of NMU-induced rat mammary carcinoma with the combination of melatonin and 9-cis-retinoic acid. Cancer Lett 2001; 168:155-163.
31. SMITH CL, CONNEELY OM, O'MALLEY BW. Modulation of the ligand-independent activation of the human estrogen receptor by hormone and antihormone. Proc Natl Acad Sci USA 1993; 90:6120-6124.
32. NAWAZ Z, LONARD DM, DENNIS AP, SMITH CL, O'MALLEY BW. Proteasome-dependent degradation of the human estrogen receptor. Proc Natl Acad Sci USA 1999; 96:1858-1862.
33. BALKAN W, COLBERT M, BOCK C, LINNEY E. Transgenic indicator mice for studying activated retinoic acid receptors during development. Proc Natl Acad Sci USA 1992; 89:3347-3351.
34. ECK-ENRIQUEZ K, KIEFER TL, SPRIGGS LL, HILL SM. Pathways through which a regimen of melatonin and retinoic acid induces apoptosis in MCF-7 human breast cancer cells. Breast Cancer Res and Treat 2000; 61:229-239.
35. MORGAN PJ, DAVIDSON G, LAWSON W, BARRETT P. Both pertussis toxin-sensitive and insensitive G-proteins link melatonin to inhibition of adenylyl cyclase in the ovine pars tuberalis. J Neuroendocrinol 1990; 2:773-776.
36. SUBRAMANIA A, KOTHARI L. Suppressive effect by melatonin on different phases of 9,10-dimethyl-1,2-benzanthracene (DMBA)-induced rat mammary gland carcinogenesis. Anticancer Drugs 1991; 2:297-303.
37. MCKENNA NJ, LANZ RB, O'MALLEY BW. Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 1999; 20:321-344.
38. LE GOFF P, MONTANO MM, SCHODIN, DJ, KATZENELLENBOGEN BS. Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity. J. Biol. Chem 1994; 269:4458-4466.
39. BOUHOUTE A, LECLERCQ G. Modulation of estradiol and DNA binding to estrogen receptor upon association with calmodulin. Biochem Biophys Res Commun 1995; 208:748-755.
40. DAI J, INSCHO EW, YUAN L, HILL SM. Modulation of intracellular calcium and calmodulin by melatonin in MCF-7 human breast cancer cells. J Pineal Res 2002; 32:1-8.
41. HUANG HJ, NORRIS JD, MCDONNELL DP. Identification of a negative regulatory surface within estrogen receptor alpha provides evidence in support of a role for corepressors in regulating cellular responses to agonists and antagonists. Mol Endocrinol 2002; 16:1778-1792.
42. DEL Rio B, PEDRERO JMG, MARTINEZ-CAMPA C, ZUAZUA P, LAZO PS, RAMOS S. Melatonin: an endogenous specific inhibitor of estrogen receptor α via calmodulin. J Biol Chem 2004; 279:38294-38302.